These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 635420)

  • 1. [Evaluation of the tumor mass and its regression under treatment of multiple myeloma of the bones. Critical comments apropos of 22 patients].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Rev Rhum Mal Osteoartic; 1978 Jan; 45(1):1-5. PubMed ID: 635420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
    Salmon SE; Durie BG
    Arch Intern Med; 1975 Jan; 135(1):131-8. PubMed ID: 1089396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of multiple bone myeloma. Prognostic features and response criteria (First part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 8-15; 55(27-30):1267-70. PubMed ID: 228397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
    Anagnostopoulos A; Aleman A; Ayers G; Donato M; Champlin R; Weber D; Alexanian R; Giralt S
    Cancer; 2004 Jun; 100(12):2607-12. PubMed ID: 15197803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment.
    Carlson K; Aström G; Nyman R; Ahlström H; Simonsson B
    Acta Radiol; 1995 Jan; 36(1):9-14. PubMed ID: 7833177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
    Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
    Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
    Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of nucleo-cytoplasmic maturation asynchrony in multiple myeloma.
    Scudla V; Wiedermann B; Kodousek R; Dusek J; Kamarád V; Indrák K
    Neoplasma; 1986; 33(4):483-92. PubMed ID: 3762809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
    Paule B; Quillard J; Bisson M; Massias P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):391-6. PubMed ID: 2454453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical considerations on a comparative study of two staging systems for multiple myeloma.
    Merlini G; Jayakar D
    Nouv Rev Fr Hematol (1978); 1984; 26(6):397-400. PubMed ID: 6527945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert radiological review of skeletal surveys identifies additional abnormalities in 23% of cases: further evidence for the value of myeloma multi-disciplinary teams in the accurate staging and treatment of myeloma patients.
    Singh J; Fairbairn KJ; Williams C; Das-Gupta EP; Russell NH; Byrne JL
    Br J Haematol; 2007 Apr; 137(2):172-3. PubMed ID: 17391500
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of criteria in staging in multiple myeloma.
    Pennec Y; Mottier D; Youinou P; Asselain B; Miossec P; Le Goff P; Le Prise PY; Le Menn G
    Haematologia (Budap); 1982; 15(2):221-6. PubMed ID: 7160667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of stratification systems in multiple myeloma. II. Clinical staging systems.
    Scudla V; Indrák K
    Neoplasma; 1985; 32(4):481-93. PubMed ID: 4047259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.